These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19117833)

  • 1. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents.
    Arpadi SM; McMahon D; Abrams EJ; Bamji M; Purswani M; Engelson ES; Horlick M; Shane E
    Pediatrics; 2009 Jan; 123(1):e121-6. PubMed ID: 19117833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.
    Arpadi SM; McMahon DJ; Abrams EJ; Bamji M; Purswani M; Engelson ES; Horlick M; Shane E
    Am J Clin Nutr; 2012 Mar; 95(3):678-85. PubMed ID: 22258265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose cholecalciferol (vitamin D
    Rovner AJ; Stallings VA; Rutstein R; Schall JI; Leonard MB; Zemel BS
    Osteoporos Int; 2017 Jan; 28(1):201-209. PubMed ID: 27837268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial.
    Glendenning P; Zhu K; Inderjeeth C; Howat P; Lewis JR; Prince RL
    J Bone Miner Res; 2012 Jan; 27(1):170-6. PubMed ID: 21956713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.
    Giacomet V; Vigano A; Manfredini V; Cerini C; Bedogni G; Mora S; Borelli M; Trabattoni D; Zuccotti GV
    HIV Clin Trials; 2013; 14(2):51-60. PubMed ID: 23611825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.
    Havens PL; Mulligan K; Hazra R; Flynn P; Rutledge B; Van Loan MD; Lujan-Zilbermann J; Kapogiannis BG; Wilson CM; Stephensen CB;
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4004-13. PubMed ID: 22933542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Safety Monitoring of 12-Month Daily 7000-IU Vitamin D3 Supplementation in Human Immunodeficiency Virus-Infected Children and Young Adults.
    Schall JI; Hediger ML; Zemel BS; Rutstein RM; Stallings VA
    JPEN J Parenter Enteral Nutr; 2016 Sep; 40(7):1057-63. PubMed ID: 26160254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different strategies of 25OH vitamin D supplementation in HIV-positive subjects.
    Falasca K; Ucciferri C; Di Nicola M; Vignale F; Di Biase J; Vecchiet J
    Int J STD AIDS; 2014 Oct; 25(11):785-92. PubMed ID: 24469972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.
    Eckard AR; Thierry-Palmer M; Silvestrov N; Rosebush JC; O'Riordan MA; Daniels JE; Uribe-Leitz M; Labbato D; Ruff JH; Singh RJ; Tangpricha V; McComsey GA
    J Steroid Biochem Mol Biol; 2017 Apr; 168():38-48. PubMed ID: 28161530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
    Muhihi A; Fawzi WW; Aboud S; Nagu TJ; Ulenga N; Wang M; Mugusi F; Sudfeld CR
    J Nutr; 2022 Aug; 152(8):1983-1990. PubMed ID: 35460249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.
    Hackman KL; Gagnon C; Briscoe RK; Lam S; Anpalahan M; Ebeling PR
    Med J Aust; 2010 Jun; 192(12):686-9. PubMed ID: 20565345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D3 every 3 months in elderly women.
    Välimäki VV; Löyttyniemi E; Pekkarinen T; Välimäki MJ
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):837-44. PubMed ID: 26725707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis.
    Armas LA; Andukuri R; Barger-Lux J; Heaney RP; Lund R
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1428-34. PubMed ID: 22798536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
    Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
    Mazzoleni S; Magni G; Toderini D
    Ital J Pediatr; 2019 Jan; 45(1):18. PubMed ID: 30691521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.
    Marwaha RK; Garg MK; Sethuraman G; Gupta N; Mithal A; Dang N; Kalaivani M; Ashraf Ganie M; Narang A; Arora P; Singh A; Chadha A; Manchanda RK
    Br J Nutr; 2019 Mar; 121(5):538-548. PubMed ID: 30843501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.
    Maalouf J; Nabulsi M; Vieth R; Kimball S; El-Rassi R; Mahfoud Z; El-Hajj Fuleihan G
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2693-701. PubMed ID: 18445674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.
    Binkley N; Gemar D; Engelke J; Gangnon R; Ramamurthy R; Krueger D; Drezner MK
    J Clin Endocrinol Metab; 2011 Apr; 96(4):981-8. PubMed ID: 21289249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation with 1000 IU vitamin D/d leads to parathyroid hormone suppression, but not increased fractional calcium absorption, in 4-8-y-old children: a double-blind randomized controlled trial.
    Abrams SA; Hawthorne KM; Chen Z
    Am J Clin Nutr; 2013 Jan; 97(1):217-23. PubMed ID: 23151536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.